These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7755558)
1. Increased expression of procoagulant activity on the surface of human platelets exposed to heavy-metal compounds. Goodwin CA; Wheeler-Jones CP; Namiranian S; Bokkala S; Kakkar VV; Authi KS; Scully MF Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):15-21. PubMed ID: 7755558 [TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity. Andersen H; Greenberg DL; Fujikawa K; Xu W; Chung DW; Davie EW Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11189-93. PubMed ID: 10500152 [TBL] [Abstract][Full Text] [Related]
3. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Dachary-Prigent J; Freyssinet JM; Pasquet JM; Carron JC; Nurden AT Blood; 1993 May; 81(10):2554-65. PubMed ID: 8490169 [TBL] [Abstract][Full Text] [Related]
4. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. Thiagarajan P; Tait JF J Biol Chem; 1991 Dec; 266(36):24302-7. PubMed ID: 1662206 [TBL] [Abstract][Full Text] [Related]
5. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Connor DE; Exner T; Ma DD; Joseph JE Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225 [TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation. Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237 [TBL] [Abstract][Full Text] [Related]
7. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors. Dachary-Prigent J; Pasquet JM; Freyssinet JM; Nurden AT Biochemistry; 1995 Sep; 34(36):11625-34. PubMed ID: 7547894 [TBL] [Abstract][Full Text] [Related]
8. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting. Podoplelova NA; Sveshnikova AN; Kotova YN; Eckly A; Receveur N; Nechipurenko DY; Obydennyi SI; Kireev II; Gachet C; Ataullakhanov FI; Mangin PH; Panteleev MA Blood; 2016 Sep; 128(13):1745-55. PubMed ID: 27432876 [TBL] [Abstract][Full Text] [Related]
9. The action of calcium-dependent protease on platelet surface glycoproteins. McGowan EB; Yeo KT; Detwiler TC Arch Biochem Biophys; 1983 Nov; 227(1):287-301. PubMed ID: 6314909 [TBL] [Abstract][Full Text] [Related]
10. Hemocompatibility of treated polystyrene substrates: contact activation, platelet adhesion, and procoagulant activity of adherent platelets. Grunkemeier JM; Tsai WB; Horbett TA J Biomed Mater Res; 1998 Sep; 41(4):657-70. PubMed ID: 9697039 [TBL] [Abstract][Full Text] [Related]
11. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Tans G; Rosing J; Thomassen MC; Heeb MJ; Zwaal RF; Griffin JH Blood; 1991 Jun; 77(12):2641-8. PubMed ID: 2043766 [TBL] [Abstract][Full Text] [Related]
12. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510 [TBL] [Abstract][Full Text] [Related]
13. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity. Kim JE; Han M; Hanl KS; Kim HK Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386 [TBL] [Abstract][Full Text] [Related]
14. Maintaining flippase activity in procoagulant platelets is a novel approach to reducing thrombin generation. Millington-Burgess SL; Harper MT J Thromb Haemost; 2022 Apr; 20(4):989-995. PubMed ID: 35034417 [TBL] [Abstract][Full Text] [Related]
16. Development of procoagulant binding sites on the platelet surface. Bevers EM; Rosing J; Zwaal RF Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834 [TBL] [Abstract][Full Text] [Related]
17. Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation. Alberio L; Ravanat C; Hechler B; Mangin PH; Lanza F; Gachet C Thromb Haemost; 2017 Jun; 117(6):1101-1114. PubMed ID: 28382366 [TBL] [Abstract][Full Text] [Related]
18. Interaction of coagulation factor Xa with human platelets. Miletich JP; Jackson CM; Majerus PW Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4033-6. PubMed ID: 333455 [TBL] [Abstract][Full Text] [Related]
19. The role of activated human platelets in prothrombin and factor X activation. Rosing J; van Rijn JL; Bevers EM; van Dieijen G; Comfurius P; Zwaal RF Blood; 1985 Feb; 65(2):319-32. PubMed ID: 3967085 [TBL] [Abstract][Full Text] [Related]